FDA seriously considering interim framework for pharmacy compounding, compounding group CEO says

Scott Brunner, CEO of the Alliance for Pharmacy Compounding, says his sense is that the FDA is seriously considering an interim framework much like what the alliance proposed and is quite interested in its technical assistance. Brunner says the Washington Post essentially confirmed this last night.

Detected & updated continuously · Source: Nebula